Analyst Ratings for Ultragenyx Pharma (RARE)
RARE Rating Summary
RARE Price Target Summary
- Highest: $140.00 (Truist Securities)
- Lowest: $50.00 (Baird)
- Average: $89.60
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$89.60 (+108.5%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
Avg. $ Target:
$89.60 (+108.5%)
* Over Last 12-Mos
Rating Score: 7.3 / 10
Percentile Rank: 77%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/18/2023 | Canaccord Genuity | Whitney Ijem | New Coverage | Buy (N/A) |
N/A (N/A) |
42.50 (42.98) |
1.13% | Details |
| 12/30/2022 | H.C. Wainwright | Ed Arce | New Coverage | Buy (N/A) |
82.00 (N/A) |
45.17 (42.98) |
-4.85% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
